A

Arena Pharmaceuticals Inc
F:RN3N

Watchlist Manager
Arena Pharmaceuticals Inc
F:RN3N
Watchlist
Price: 90.5 EUR 0.56% Market Closed
Market Cap: 5.6B EUR

Intrinsic Value

RN3N price has not been updated for more than 10 months. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the intrinsic value of RN3N.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RN3N Intrinsic Value
Not Available
Base Case Scenario
Compare RN3N to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about RN3N?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arena Pharmaceuticals Inc

Current Assets 569.5m
Cash & Short-Term Investments 550.5m
Other Current Assets 19m
Non-Current Assets 215.2m
Long-Term Investments 160.8m
PP&E 28.2m
Other Non-Current Assets 26.2m
Current Liabilities 66.3m
Accounts Payable 13.3m
Accrued Liabilities 48m
Other Current Liabilities 5.1m
Non-Current Liabilities 45.2m
Long-Term Debt 36.2m
Other Non-Current Liabilities 9m
Efficiency

Free Cash Flow Analysis
Arena Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Arena Pharmaceuticals Inc

Revenue
54k USD
Operating Expenses
-545.7m USD
Operating Income
-545.7m USD
Other Expenses
-70.7m USD
Net Income
-616.4m USD
Fundamental Scores

RN3N Profitability Score
Profitability Due Diligence

Arena Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Arena Pharmaceuticals Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

RN3N Solvency Score
Solvency Due Diligence

Arena Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Arena Pharmaceuticals Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RN3N Price Targets Summary
Arena Pharmaceuticals Inc

There are no price targets for RN3N.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for RN3N is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y